SCM
MED icon

Sterling Capital Management’s Medifast MED Stock Holding History

Sterling Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-357
Closed -$3.64K – 3367
2026
Q1 		$3.64K Sell
357
-264
-43% -$2.85K ﹤0.01% 2835
2025
Q4 		$6.63K Sell
621
-123
-17% -$1.47K ﹤0.01% 2792
2025
Q3 		$10.2K Buy
744
+440
+145% +$6.15K ﹤0.01% 2479
2025
Q2 		$4.27K Buy
304
+118
+63% +$1.55K ﹤0.01% 2593
2025
Q1 		$2.51K Sell
186
-159
-46% -$2.39K ﹤0.01% 2504
2024
Q4 		$6.08K Buy
345
+311
+915% +$5.77K ﹤0.01% 2367
2024
Q3 		$651 Buy
+34
New +$655 ﹤0.01% 2751
2016
Q3 		– Sell
-105,030
Closed -$3.49M – 943
2016
Q2 		$3.49M Sell
105,030
-77,811
-43% -$2.51M 0.03% 289
2016
Q1 		$5.52M Sell
182,841
-1,175
-0.6% -$34.3K 0.05% 237
2015
Q4 		$5.59M Sell
184,016
-125
-0.1% -$3.72K 0.05% 239
2015
Q3 		$4.95M Sell
184,141
-3,805
-2% -$111K 0.04% 245
2015
Q2 		$6.07M Sell
187,946
-4,430
-2% -$140K 0.05% 174
2015
Q1 		$5.77M Sell
192,376
-27,176
-12% -$863K 0.05% 190
2014
Q4 		$7.37M Sell
219,552
-62,275
-22% -$1.94M 0.06% 135
2014
Q3 		$9.25M Sell
281,827
-62,395
-18% -$1.92M 0.11% 118
2014
Q2 		$10.5M Sell
344,222
-145,463
-30% -$4.53M 0.09% 117
2014
Q1 		$14.2M Sell
489,685
-1,975
-0.4% -$52.9K 0.12% 111
2013
Q4 		$12.8M Buy
491,660
+372,549
+313% +$9.55M 0.12% 115
2013
Q3 		$3.2M Buy
+119,111
New +$3.19M 0.04% 177

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sterling Capital Management's MED Position: Q2 2026 in Review

Sterling Capital Management sold out of Medifast (MED) in Q2 2026, closing a stake of 357 shares — an estimated $3.64K sold.

Sterling Capital Management first reported a position in MED in Q3 2013 and held it in 19 quarters. The position peaked at $14.2M in Q1 2014. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Sterling Capital Management reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 357 Medifast shares in Q2 2026, an estimated $3.64K.
  • Sterling Capital Management first reported a position in Medifast in Q3 2013 and held it in 19 quarters.
  • Sterling Capital Management's Medifast position peaked at $14.2M in Q1 2014.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.